In 2017, Gu et al. revealed that PA treatment (15–45 mg/kg) for experimental colitis mice could ameliorate the apoptosis in colitis tissues through inhibiting MAPK/NF-κB pathway (Gu et al., 2017). Here, NFKB1 is linked to colitis.